VIDEO: "Too good to treat" stroke patients may benefit from tPA

This is f*cking appalling. Because the stroke medical world has put all their eggs in one basket - tPA, these people are totally screwed. Maybe if your doctor would look at   these 31 hyperacute possibilities I'm going to insist my doctor give me the first week. 
Or these 177 hyperacute therapies that need more research.
Damn it all, have your doctor do something useful, solve some of the problems in stroke.
Does this contradict this earlier research?

Outcomes mostly favorable for ‘too good to treat’ stroke patients

http://www.healio.com/cardiology/stroke/news/online/%7B87954125-bb0e-4c90-920d-f0faa8ad2c76%7D/video-too-good-to-treat-stroke-patients-may-benefit-from-tpa 
 Khwaja Siddiqui, MD, clinical research fellow in the department of neurology at the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care, outlines his study on predictors of poor outcomes among patients with stroke considered "too good to treat."
Patients with stroke who present within the window for treatment with IV tPA but have mild or rapidly improving symptoms are not usually treated, Siddiqui said at the International Stroke Conference. However, prior research has indicated that patients who do not receive treatment at presentation for this reason experience poor outcomes.
In this trial, researchers evaluated 238 patients with evaluable baseline and infarct characteristics who did not receive treatment on presentation due to mild or improving symptoms. A good outcome was defined as discharge home from the hospital, while negative outcomes included discharge elsewhere or death. Multivariate analysis indicated that advanced age, Hispanic ethnicity, bihemispheric infarcts and higher score on the NIH Stroke Scale were independent predictors of poor outcomes without treatment.
Siddiqui said this study provides a basis for recognizing patients with stroke who present with symptoms that would normally be considered "too good to treat," but may benefit from TPA.